PCIA
CNMD icon

Prime Capital Investment Advisors’s CONMED CNMD Stock Holding History

Prime Capital Investment Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-74
Closed -$8K – 497
2019
Q4 		$8K Hold
74
– – ﹤0.01% 515
2019
Q3 		$7K Buy
+74
New +$6.95K ﹤0.01% 563

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Prime Capital Investment Advisors's CNMD Position: Q1 2020 in Review

Prime Capital Investment Advisors sold out of CONMED (CNMD) in Q1 2020, closing a stake of 74 shares — an estimated $8K sold.

Prime Capital Investment Advisors first reported a position in CNMD in Q3 2019 and held it in 2 quarters. The position peaked at $8K in Q4 2019. 229 funds tracked by Wall St. Rank hold CNMD as of Q1 2020.

  • Prime Capital Investment Advisors reported no remaining CONMED position as of Q1 2020 after selling out during the quarter.
  • Prime Capital Investment Advisors sold 74 CONMED shares in Q1 2020, an estimated $8K.
  • Prime Capital Investment Advisors first reported a position in CONMED in Q3 2019 and held it in 2 quarters.
  • Prime Capital Investment Advisors's CONMED position peaked at $8K in Q4 2019.
  • 229 funds tracked by Wall St. Rank held CONMED as of Q1 2020.

Based on Prime Capital Investment Advisors's 13F filing for Q1 2020, filed 4 May 2020.